Skip to content
Tissue
Metastatic
Disease
Adult hepatocellular carcinoma
Metastatic site
Ascites (metastatic)
Synonyms
Jhh-2, JHH2

Documents

JHH-2

Cell line · Product number 305768

CA$430.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

JHH-2 is a human hepatocellular carcinoma (HCC) cell line established from an ascites metastasis of a 56-year-old Japanese male patient. The line grows as an adherent monolayer with spindle-shaped cell morphology. JHH-2 harbors a TP53 p.His83Tyr heterozygous mutation affecting the transactivation domain of p53, which impairs wild-type p53 transcriptional activity and is associated with reduced apoptotic responses to DNA damage. This mutation, combined with the metastatic ascites origin of the line, makes JHH-2 a relevant model for studying advanced, metastatic HCC biology.

JHH-2 is applicable in hepatocellular carcinoma research, including studies of HCC cell invasion and migration, TP53 mutation-associated phenotypes, resistance to sorafenib and other targeted agents, and evaluation of novel therapeutic strategies against advanced HCC. The ascites origin suggests an aggressive, metastatic phenotype, making JHH-2 suitable for studies of HCC dissemination and the biology of liver cancer with acquired p53 dysfunction. It is also used as a xenograft model in immunocompromised hosts.

JHH-2 is maintained as an adherent culture in Williams' E medium supplemented with 10% FBS (originally 10%, subsequently 2% FCS after 5 years; alternative: MEM + 10% FBS). Cells are subcultured using 0.02% EDTA + 0.25% trypsin. Recommended seeding density is 1 × 10⁵ cells/cm². Doubling time is approximately 33–150 hours depending on conditions.

Tissue
Metastatic
Disease
Adult hepatocellular carcinoma
Metastatic site
Ascites (metastatic)
Applications
Hepatocellular carcinoma research; HCC invasion and migration; TP53-mutant HCC biology; sorafenib resistance; advanced HCC modeling; xenograft studies; liver cancer drug evaluation
Synonyms
  • Jhh-2
  • JHH2

02Classification

Organism
Human
Sex
Male
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; wildtype cell line
Biosafety level
1

03Characteristics

Morphology
Spindle-shaped
Cell type
Hepatocyte-like
Doubling time
150 hours ; 60.12 hours ; 35-70 hours , ~2 days , ~33 hours , ~59 hours

04Identifiers

Citation
JHH-2 (Cytion catalog number 305768)
NCBI TaxID
9606
Cellosaurus
CVCL_2786

05Expression and susceptibility

Mutational profile
Mutation: p.His83Tyr, Heterozygous

06Handling and culture

Culture medium
Williams'E medium with 10% fetal calf serum originally and later 2% FCS is used for 5 years. (alternative MEM 90% + FBS 10%)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS (or 2% FCS for long-term passage)
Dissociation reagent
0.02% EDTA + 0.25% Trypsin
Split ratio
1 to 3
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Quality control and cryopreservation

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
56Y
Ethnicity
Japanese

10Product details

Composition table